
Genome&Company — Investor Relations & Filings
Genome&Company is a clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapeutics. The company's research and development pipeline is centered on two primary platforms: microbiome-based pharmaceuticals and novel immune checkpoint inhibitors for immuno-oncology. Its drug candidates are derived from its proprietary microbiome platform and are aimed at treating a range of diseases, with a significant focus on cancer. In addition to its pharmaceutical programs, the company develops and markets consumer healthcare products, including dietary supplements and cosmeceuticals, leveraging its expertise in microbes and probiotics.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 주식등의대량보유상황보고서(일반) | 2026-05-29 | Korean | |
| 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-05-29 | Korean | |
| 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-05-29 | Korean | |
| 주식등의대량보유상황보고서(약식) | 2026-05-27 | Korean | |
| 주식등의대량보유상황보고서(약식) | 2026-05-27 | Korean | |
| 분기보고서 (2026.03) | 2026-05-15 | Korean |
Browse filings by year
9 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 47884067 | 주식등의대량보유상황보고서(일반) | 2026-05-29 | Korean | ||
| 47884062 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-05-29 | Korean | ||
| 47884044 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-05-29 | Korean | ||
| 47356804 | 주식등의대량보유상황보고서(약식) | 2026-05-27 | Korean | ||
| 47355952 | 주식등의대량보유상황보고서(약식) | 2026-05-27 | Korean | ||
| 46367086 | 분기보고서 (2026.03) | 2026-05-15 | Korean | ||
| 45961679 | [기재정정]주식매수선택권부여에관한신고 | 2026-05-14 | Korean | ||
| 45961049 | [기재정정]주식매수선택권부여에관한신고 | 2026-05-14 | Korean | ||
| 45948959 | [기재정정]주식매수선택권부여에관한신고 | 2026-05-14 | Korean | ||
| 45907657 | [기재정정]주식매수선택권부여에관한신고 | 2026-05-14 | Korean | ||
| 45906494 | [기재정정]주식매수선택권부여에관한신고 | 2026-05-14 | Korean | ||
| 45905939 | [기재정정]주식매수선택권부여에관한신고 | 2026-05-14 | Korean | ||
| 45905446 | [기재정정]주식매수선택권부여에관한신고 | 2026-05-14 | Korean | ||
| 45905381 | [기재정정]주식매수선택권부여에관한신고 | 2026-05-14 | Korean | ||
| 45904842 | [기재정정]주식매수선택권부여에관한신고 | 2026-05-14 | Korean | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Ajanta Pharma Ltd.
Specialty pharmaceutical firm focused on complex generics a…
|
AJANTPHARM | IN | Manufacturing |
|
Akari Therapeutics Plc
Develops next-gen antibody-drug conjugates using proprietar…
|
AKTX | US | Manufacturing |
|
Akebia Therapeutics, Inc.
A biopharmaceutical company that develops and commercialize…
|
AKBA | US | Manufacturing |
|
Akeso, Inc.
Global commercial-stage biopharma developing innovative ant…
|
9926 | KY | Manufacturing |
|
Aktis Oncology, Inc.
A clinical-stage biotech developing targeted alpha radiopha…
|
AKTS | US | Manufacturing |
|
Akums Drugs and Pharmaceuticals Limited
CDMO providing end-to-end pharmaceutical manufacturing and …
|
AKUMS | IN | Manufacturing |
|
Albert David Ltd.
Produces pharmaceutical formulations, infusions, and specia…
|
ALBERTDAVD | IN | Manufacturing |
|
Aldeyra Therapeutics, Inc.
Develops medications for immune-mediated ocular and systemi…
|
ALDX | US | Manufacturing |
|
Aleafia Health Inc.
Vertically integrated cannabis company with cultivation, pr…
|
AH | CA | Manufacturing |
|
Alector, Inc.
Clinical-stage biotech using immuno-neurology to treat neur…
|
ALEC | US | Manufacturing |
Genome&Company via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/16628/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=16628 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=16628 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=16628 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 16628}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Genome&Company (id: 16628)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.